DCDanila Coradini

Danila Coradini

*This is an algorithmically generated author record based on publicly available information.

Danila Coradini has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Maria Grazia Daidone

    Biomarkers Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    7 shared publications
  • Cinzia Pellizzaro

    Department of Experimental Oncology, Determinants of Prognosis and Treatment Response Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy

    4 shared publications
  • C Pellizzaro

    Department of Experimental Oncology, Determinants of Prognosis and Treatment Response Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy

    2 shared publications
  • Elia Biganzoli

    University of Milan

    2 shared publications
  • Gabriella Abolafio

    Department of Clinical Neuroscience (S.M., M. Costanza, R.P.), Foundation Neurological Institute IRCCS C. Besta, Milan; Department of Molecular and Translational Medicine (P.L.P., E.F., M. Cominelli), Pathology Unit, University of Brescia; Department of Experimental Oncology and Molecular Medicine (G.A.), Fondazione IRCCS "Istituto Nazionale dei Tumori," Milan, Italy; and Department of Neurology and Neurological Sciences (L.S.), Stanford University School of Medicine, CA

    2 shared publications
  • Giovanni Di Fronzo

    From the Unità Operativa Determinanti Biomolecolari nella Prognosi e Terapia; Statistica Medica e Biometria; Unità di Chirurgia Ginecologica; Unità di Anatomia PatologicaIstituto Nazionale per lo Studio e la Cura dei Tumori; Istituto di Statistica Medica e Biometria, Università degli Studi; and Centro per lo Studio della Patologia Cellulare, Consiglio Nazionale delle Ricerche, Milan, Italy

    2 shared publications

Latest Publications

  • Open Access

    Infiltrating ductal and lobular breast carcinomas are characterised by different interrelationships among markers related to angiogenesis and hormone dependence

    by D Coradini, C Pellizzaro, S Veneroni, L Ventura, M G Daidone

    To obtain a more integrated understanding of the different breast cancer phenotypes and to investigate whether bio-molecular profiles can distinguish between specific histotypes, we explored the interrelations among several biologic variables indicative of, or related to, hormone dependence, proliferation and apoptosis control, and angiogenesis in ductal and lobular carcinomas, the most common histotypes. Oestrogen and progesterone receptors, tumour proliferative activity, the expression of cyclin A, p16ink4A, p27kip1, p21waf1, p53, bcl-2, and levels of vascular endothelial growth factor and hypoxia-inducible factor-1α (HIF-1α) were evaluated in 190 in ductal and 67 lobular carcinomas. Our findings support the hypothesis that in ductal and lobular carcinomas are two distinct, partially phenotypically unrelated entities, the latter being characterised by the presence of features indicative of differentiation such as oestrogen receptors, low proliferation and lack of p53 expression and associated with low vascular endothelial growth factor content compared to angiogenesis in ductal carcinomas. Conversely, no significant difference was found between lobular carcinomas and in ductal carcinomas considering the frequency distribution of PgR-positive cases, cyclin-dependent kinase inhibitors acting at the G1/S boundary, bcl-2 and HIF-1α protein expression. Although both generally defined as hormone responsive, in ductal and lobular carcinomas are also characterised by biologic patterns in which proteins related to hormone responsiveness, cell-cycle control, apoptosis and angiogenesis were differently associated. This finding suggests the need to refine breast cancer characterisation in order to provide detailed information about individual tumours, or subsets of tumours, that will help in defining optimal treatment approaches.


  • Open Access

    Modulation of angiogenesis-related proteins synthesis by sodium butyrate in colon cancer cell line HT29

    by Cinzia Pellizzaro, Danila Coradini, Maria Grazia Daidone

    Sodium butyrate (NaB), a short-chain fatty acid naturally present in the human colon, is able to induce cell cycle arrest, differentiation and apoptosis in colon cancer cells. In addition to these effects, we investigated the effect of NaB on two angiogenesis-related proteins in a colon carcinoma cell line (HT29): vascular endothelial growth factor (VEGF), the most potent angiogenic factor, and hypoxia-inducible factor (HIF)-1α, the main transcription activator of the VEGF gene, which are both constitutively expressed at high levels in HT29 also in normoxic conditions. NaB treatment had a different effect on VEGF165 and HIF-1α expression. In fact, it induced a dose-dependent down regulation of the VEGF165 protein level that was not paralleled by a concomitant down regulation of the corresponding mRNA, suggesting a post-translational regulation of the factor. Conversely, after 24 h of treatment all the tested NaB concentrations reduced the HIF-1α protein level, whereas after a longer time of exposure HIF-1α level increased in the presence of a high NaB concentration (2 mM) with a concomitant increase in HIF-1α mRNA. These results indicate that NaB, besides regulating other fundamental cellular processes, is able to modulate the expression of two important angiogenesis-related molecules and suggested a further possible clinical application of this short-chain fatty acid as an anti-angiogenic compound in association with conventional chemotherapeutic agents.


  • Open Access

    Modulation of cell cycle-related protein expression by sodium butyrate in human non-small cell lung cancer cell lines

    by Cinzia Pellizzaro, Danila Coradini, Antonella Daniotti, Gabriella Abolafio, Maria Grazia Daidone

    To elucidate the mechanism of action of sodium butyrate (NaB), we examined its effect on the expression of some cell cycle‐related proteins (cyclins D1 and E, p16ink4, p21waf1, p27kip1) in 2 human non‐small cell lung cancer cell lines (NCI‐460 and NCI‐H23) characterized by wild‐ type and mutant TP53, respectively. The growth of both cell lines was inhibited in a dose‐dependent manner and this process was accompanied by a modulation of cell cycle‐related proteins. In NCI‐H460, the p27kip1 and p16ink4 protein levels were markedly increased following NaB treatment, whereas p21waf1 was only slightly elevated, with a peak at 2 mM NaB, and p53 was unaffected by any concentration. By contrast, in NCI‐H23, a marked increase in p21waf1 protein was paralleled by decreased p53 levels, whereas all the other investigated proteins remained stable. The results suggest that NaB blocks the growth of both cell lines by induction of cyclin‐dependent kinase inhibitors (in particular, p21waf1 in NCI‐H23 and p27kip1 and p16ink4 in NCI‐H460) through a p53‐dependent or p53‐independent mechanism, and open up interesting perspectives for the use of NaB as an alternative or additional strategy in the treatment of non‐small cell lung carcinoma.


  • Time-Dependent Relevance of Steroid Receptors in Breast Cancer

    by Danila Coradini, Maria Grazia Daidone, Patrizia Boracchi, Elia Biganzoli, Saro Oriana, Gianluigi Bresciani, Cinzia Pellizzaro, Gorana Tomasic, Giovanni Di Fronzo, Ettore Marubini

    PURPOSE: To analyze the time-dependent prognostic role of the investigated variables, considered, when appropriate, on a continuous scale, for the purpose of evaluating and describing the interrelationships between clinically relevant patient and tumor characteristics (age, size and histology, and estrogen receptor [ER] and progesterone receptor content) and the risk of new disease manifestation. PATIENTS AND METHODS: We applied a flexible statistical model to a case series of 1,793 patients with axillary lymph node–negative breast cancer with a minimal potential follow-up of 10 years. To avoid a potential confounding effect of adjuvant treatment, only patients given local-regional therapy until relapse were considered. RESULTS: ER content and tumor size (adjusted for all the other covariates) showed a time-dependent relationship with the risk of new disease manifestations. In particular, ER content failed to show a prognostic effect within the first years of follow-up; thereafter, a positive association with risk of relapse was observed. For tumor size, within the first years of follow-up, the risk of relapse was directly related to size for only tumors up to 2.5 cm in diameter; thereafter, the impact on prognosis progressively decreased. CONCLUSION: The availability of a long follow-up on a large breast cancer series, as well as the use of innovative statistical approaches, allowed us to explore the functional relation between steroid receptors and clinical outcome and to generate a hypothesis on the involvement of ER in favoring long-term metastasis development.


  • Open Access

    Sodium butyrate modulates cell cycle‐related proteins in HT29 human colonic adenocarcinoma cells

    by D. Coradini, C. Pellizzaro, D. Marimpietri, G. Abolafio, M. G. Daidone

    Sodium butyrate (NaB), a product of colonic fermentation of dietary fibre, has been shown to inhibit cell proliferation by blocking cells in the G0/G1 phase of the cell cycle through a mechanism of action still not completely understood. We investigated the effect of NaB on the level of some G1 phase‐related proteins in a colon carcinoma cell line (HT29). In particular, we addressed our attention to cyclin D1 (the key regulator of G1S progression), p21waf1/cip1 (the main inactivator of the cyclin D/cdk complex), and p53 (the most important regulator of p21waf1/cip1 gene transcription). At inhibitory concentrations (higher than 1 mM) NaB reduced cyclin D1 and p53 level in a dose‐dependent manner and sustained the synthesis of p21waf1/cip1, probably in a p53‐independent way, accounting for the G0/G1 block observed by flow cytometry. Present results provide further evidence on the molecular mechanism at the basis of the physiological role of NaB and support the hypothesis that an unbalanced diet, poor in carbohydrates and therefore in NaB, could result in functional alterations with clinical and carcinogenic implications.


  • Open Access

    Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancer

    by Maria Grazia Daidone, Silvia Veneroni, Elvira Benini, Gorana Tomasic, Danila Coradini, Marinella Mastore, Cristina Brambilla, Laura Ferrari, Rosella Silvestrini


  • Open Access

    Relationship between Steroid Receptors (As Continuous Variables) and Response to Adjuvant Treatments in Postmenopausal Women with Node-Positive Breast Cancer

    by D. Coradini, S. Oriana, E. Biganzoli, E. Marubini, P. Boracchi, G. Bresciani, G. Di Fronzo, M.G. Daidone

    In current clinical practice for breast cancer patients, estrogen (ER) and progesterone receptor (PgR) concentrations, quantified by the dextran-coated charcoal assay, are categorized by an arbitrary cutoff into a negative or positive status. However, although the results obtained with this approach are easy to interpret, such a representation could oversimplify the relationship between ER and PgR content and patient outcome and imply an assumption of monotonicity, which is generally expected but rarely proven. We evaluated the relationship between ER and PgR content (considered on a continuous scale) and clinical outcome, using a flexible statistical model, in a group of postmenopausal patients with N-positive operable tumors who were submitted to surgery and different adjuvant treatments (tamoxifen or CMF). Univariate analysis indicated that in the tamoxifen-treated group, ER level, number of metastatic nodes (pN) and age, but not PgR, were significant indicators of clinical outcome (p=0.032, p=0.021 and p=0.029, respectively). Multivariate analysis indicated that in this group of patients there was no interaction between variables, and in the final model for disease-free survival (DFS) only ER and pN were retained with an overall predictive ability of the regression model of 0.723, as evaluated by Harrell's c. However, pN markedly contributed to the predictive ability of the model with respect to ER, since a marked decrease in Harrell's c statistic (c=0.582) was observed when pN was removed from the model. In the CMF-treated group, only pN affected clinical outcome. When the estimated DFS curves obtained from the final Cox regression models were plotted according to four values of ER (in the tamoxifen-treated group) or three values of pN (in the CMF-treated group) we observed that in the tamoxifen-treated group patients with an ER concentration equal to 0 fmol/mg cytosol protein had the worst prognosis, whereas a marked improvement of the expected DFS was observed for patients with a low but detectable ER level (generally classified as ER-negative because falling below the conventional cutoff value of 10 fmol/mg cytosol protein). Our results seem to suggest that the use of steroid receptor concentrations on a continuous scale, instead of dichotomous “status”, is to be preferred in the choice of adequate therapeutic strategies.


  • Open Access

    Effect of steroid receptors, pS2 and cathepsin D on the outcome of elderly breast cancer patients: An exploratory investigation

    by Danila Coradini, Elia Biganzoli, Patrizia Boracchi, Emilio Bombardieri, Ettore Seregni, Giuseppe De Palo, Gabriele Martelli, Giovanni Di Fronzo

    • 6 May 1998
      • Vol. 18, 177-82

    Effect of liposome-encapsulated alpha- or beta-interferon on breast cancer cell lines.

    by D Coradini, C Pellizzaro, A Biffi, L Lombardi, E Pirronello, L Riva, G Di Fronzo

    Experimental evidence and clinical studies have indicated that interferons (IFN) inhibit proliferation in a wide panel of neoplasms, including breast cancer. However, the antitumor activity of IFN requires the continuous presence of high concentrations of the drug and is associated with side effects. To explore the potential of liposomes as an IFN delivery system, we compared the effect of free or liposome-encapsulated alpha-IFN and beta-IFN on the growth of two breast cancer cell lines (MCF7 and MDA-MB231). Cells were cultured in the presence of IFN at different concentrations (500, 1000, 2000 IU/ml) or in the presence of multilamellar liposomes (phosphatidylcholine-phosphatidylserine at a molar ratio of 7:3) containing saline buffer, alpha-IFN or beta-IFN. Additional control groups consisted of cells cultured with alpha-IFN or beta-IFN plus empty liposomes. Empty liposomes were not cytotoxic and did not interfere with IFN activity. In both cell lines liposomes encapsulating alpha-IFN (at the highest lipid:drug ratio) inhibited cell growth in a manner similar to that of free alpha-IFN, whereas liposomes encapsulating beta-IFN showed slightly, lower inhibition than free beta-IFN, this was more evident in MCF7 cells. The present results indicate that liposomes encapsulating alpha-IFN or beta-IFN were effective on the growth of both breast cancer cell lines, which are characterized by a different estrogen responsiveness, and that they might be a useful carrier system for the delivery of high doses of IFN.